We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Alliance Pharma Plc | LSE:APH | London | Ordinary Share | GB0031030819 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 35.00 | 35.00 | 35.10 | 35.20 | 34.25 | 35.00 | 459,327 | 11:51:46 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 167.42M | 936k | 0.0017 | 207.06 | 190.13M |
TIDMAPH
RNS Number : 2405E
Alliance Pharma PLC
07 April 2014
For immediate release 7 April 2014
ALLIANCE PHARMA PLC
("Alliance" or the "Company")
TR-1: Notification of Major Interest in Shares
1. Identity of the issuer or the underlying Alliance Pharma plc issuer of existing shares to which voting rights are attached: ----------------------------------------------------- ---------------------------------- 2 Reason for the notification (please tick the appropriate box or boxes): ----------------------------------------------------------------------------------------- An acquisition or disposal of voting rights x -------------------------------------------------------------------------------- ------- An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached -------------------------------------------------------------------------------- ------- An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments -------------------------------------------------------------------------------- ------- An event changing the breakdown of voting rights -------------------------------------------------------------------------------- ------- Other (please specify): --------------------------- --------------------------------------------------- ------- 3. Full name of person(s) subject Brown Shipley & Co Limited to the notification obligation: ----------------------------------------------- ---------------------------------------- 4. Full name of shareholder(s) N/A (if different from 3.): ----------------------------------------------- ---------------------------------------- 5. Date of the transaction and date 04/04/2014 on which the threshold is crossed or reached: ----------------------------------------------- ---------------------------------------- 6. Date on which issuer notified: 07/04/2014 ----------------------------------------------- ---------------------------------------- 7. Threshold(s) that is/are crossed or reached: 3.01% ----------------------------------------------- ---------------------------------------- 8. Notified details: ---------------------------------------------------------------------------------------------------------------------- A: Voting rights attached to shares ---------------------------------------------------------------------------------------------------------------------- Class/type Situation previous Resulting situation after the triggering of to the triggering transaction shares transaction if possible using the ISIN CODE -------------- ------------------------------- --------------------------------------------------------------------- Number Number Number Number of voting % of voting rights of of of shares rights Shares Voting Rights -------------- ---------------- ------------- ----------- ----------------------------- ------------------------- Direct Direct Indirect Direct Indirect -------------- ------ -------- ----- ------ ----------- -------------- ------------- --------- -------------- GG0031030819 7,815,845 7,815,845 7,941,145 7,941,145 3.01% -------------- ---------------- ------------- ----------- -------------- ------------- --------- -------------- B: Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------------------------- Type of financial Expiration Exercise/ Number of voting % of voting instrument date Conversion Period rights that may rights be acquired if the instrument is exercised/ converted. ---------------------- --------------- ------------------------- ---------------------------- -------------------- C: Financial Instruments with similar economic effect to Qualifying Financial Instruments ---------------------------------------------------------------------------------------------------- Resulting situation after the triggering transaction ---------------------------------------------------------------------------------------------------- Type of financial Exercise Expiration Exercise/ Number of voting % of voting rights instrument price date Conversion rights instrument period refers to ------------------ --------- ----------- ------------ ------------------- --------------------- Nominal Delta ------------------ --------- ----------- ------------ ------------------- ----------- -------- Total (A+B+C) ------------------------------------------------------ Number of voting rights Percentage of voting rights ------------------------ ---------------------------- 7,815,845 3.01% ------------------------ ---------------------------- 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: -------------------------------------------------------------------------------- Proxy Voting: -------------------------------------------------------------------------------- 10. Name of the proxy holder: --------------------------------------------------- --------------------------- 11. Number of voting rights proxy holder will cease to hold: --------------------------------------------------- --------------------------- 12. Date on which proxy holder will cease to hold voting rights: --------------------------------------------------- --------------------------- 13. Additional information: ---------------------------------------- -------------------------------------- 14. Contact name: Kieron Brooks ---------------------------------------- -------------------------------------- 15. Contact telephone number: 020 7282 3206 ---------------------------------------- --------------------------------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLXDLFBZZFZBBB
1 Year Alliance Pharma Chart |
1 Month Alliance Pharma Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions